Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 3
1995 5
1996 6
1997 2
1998 4
1999 5
2000 5
2001 4
2002 6
2003 3
2004 4
2005 3
2006 3
2007 2
2008 2
2009 3
2010 5
2011 3
2012 4
2013 4
2014 2
2015 8
2016 7
2017 2
2018 4
2019 4
2020 2
2021 2
2022 4
2023 5
2024 1
2025 4
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Results by year

Citations

7 articles found by citation matching
Show all

Search results

Filters applied: . Clear all
Page 1
Dysmenorrhea, Endometriosis and Chronic Pelvic Pain in Adolescents.
Sachedina A, Todd N. Sachedina A, et al. J Clin Res Pediatr Endocrinol. 2020 Feb 6;12(Suppl 1):7-17. doi: 10.4274/jcrpe.galenos.2019.2019.S0217. J Clin Res Pediatr Endocrinol. 2020. PMID: 32041388 Free PMC article.
Adolescents can safely be offered menstrual suppression with combined hormonal contraception, and progestin-only options. When the above are ineffective, gonadotropin releasing hormone agonists with add back treatment can be considered. T …
Adolescents can safely be offered menstrual suppression with combined hormonal contraception, and progestin-only options. When the above are …
Endometriosis: Evaluation and Treatment.
Edi R, Cheng T. Edi R, et al. Am Fam Physician. 2022 Oct;106(4):397-404. Am Fam Physician. 2022. PMID: 36260896 Free article. Review.
Although transvaginal ultrasonography is used to evaluate endometriosis of deep pelvic sites to rule out other causes of pelvic pain, magnetic resonance imaging is preferred if deep infiltrating endometriosis is suspected. ...Second-line treatments include gonado …
Although transvaginal ultrasonography is used to evaluate endometriosis of deep pelvic sites to rule out other causes of pelvic pain, …
Chronic Pelvic Pain in Women.
Speer LM, Mushkbar S, Erbele T. Speer LM, et al. Am Fam Physician. 2016 Mar 1;93(5):380-7. Am Fam Physician. 2016. PMID: 26926975 Free article. Review.
Referral for diagnostic evaluation of endometriosis by laparoscopy is usually indicated in severe cases. Curative treatment is elusive, and evidence-based therapies are limited. Patient engagement in a biopsychosocial approach is recommended, with treatment of any i …
Referral for diagnostic evaluation of endometriosis by laparoscopy is usually indicated in severe cases. Curative treatment is elusiv …
Low-dose add-back therapy during postoperative GnRH agonist treatment.
Tsai HW, Wang PH, Huang BS, Twu NF, Yen MS, Chen YJ. Tsai HW, et al. Taiwan J Obstet Gynecol. 2016 Feb;55(1):55-9. doi: 10.1016/j.tjog.2015.04.004. Taiwan J Obstet Gynecol. 2016. PMID: 26927249 Free article. Clinical Trial.
OBJECTIVE: Low-dose add-back therapy during postoperative GnRH agonist treatment could lower the risk of add-back-induced endometriosis recurrence and reduce treatment dropout compared with a regular dose. However, the effec …
OBJECTIVE: Low-dose add-back therapy during postoperative GnRH agonist treatment could lower the risk of …
Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy.
Bedaiwy MA, Allaire C, Alfaraj S. Bedaiwy MA, et al. Fertil Steril. 2017 Mar;107(3):537-548. doi: 10.1016/j.fertnstert.2016.12.024. Epub 2017 Jan 27. Fertil Steril. 2017. PMID: 28139239 Free article. Review.
Dienogest and gonadotropin-releasing hormone (GnRH) analogues with hormone add-back therapy seem to be equally effective for long-term treatment of pain symptoms associated with endometriosis. There is insufficient ev …
Dienogest and gonadotropin-releasing hormone (GnRH) analogues with hormone add-back ther …
Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up.
Surrey ES, Hornstein MD. Surrey ES, et al. Obstet Gynecol. 2002 May;99(5 Pt 1):709-19. doi: 10.1016/s0029-7844(02)01945-2. Obstet Gynecol. 2002. PMID: 11978277 Clinical Trial.
OBJECTIVE: To assess post-treatment effects in endometriosis patients of a 12-month course of GnRH agonist alone or with one of three "add-back" regimens. ...CONCLUSION: GnRH agonist and norethindrone acetate alone or combined with …
OBJECTIVE: To assess post-treatment effects in endometriosis patients of a 12-month course of GnRH agonist alone or wit …
The role of GnRH agonists plus add-back therapy in the treatment of endometriosis.
Gargiulo AR, Hornstein MD. Gargiulo AR, et al. Semin Reprod Endocrinol. 1997;15(3):273-84. doi: 10.1055/s-2008-1068757. Semin Reprod Endocrinol. 1997. PMID: 9383836 Review.
Agonistic analogs of GnRH have emerged as effective drugs in the treatment of pelvic pain associated with endometriosis. ...In strict analogy, as oral progestins have been shown to improve bone mass in postmenopausal women, regimens employing progestin add …
Agonistic analogs of GnRH have emerged as effective drugs in the treatment of pelvic pain associated with endometriosis …
Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show?
Surrey ES. Surrey ES. Curr Opin Obstet Gynecol. 2010 Aug;22(4):283-8. doi: 10.1097/GCO.0b013e32833b35a7. Curr Opin Obstet Gynecol. 2010. PMID: 20498596 Review.
Gonadotropin-releasing hormone agonists (GnRHa) have emerged as a primary medical therapy for patients with symptomatic disease, but secondary hypoestrogenic side effects may limit compliance. ...The subset of adolescents with endometriosis …
Gonadotropin-releasing hormone agonists (GnRHa) have emerged as a primary medical therapy for patients wi …
"Add-back" therapy for endometriosis in adolescents.
Lubianca JN, Gordon CM, Laufer MR. Lubianca JN, et al. J Reprod Med. 1998 Mar;43(3):164-72. J Reprod Med. 1998. PMID: 9564639 Review.
OBJECTIVE: To review the impact of gonadotropin-releasing hormone agonists (GnRH-as) on bone mass in adolescents and options for GnRH-a with "add-back" for long-term therapy for adolescents with endometriosis n …
OBJECTIVE: To review the impact of gonadotropin-releasing hormone agonists (GnRH-as) on bone mass in adol …
Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial.
DiVasta AD, Feldman HA, Sadler Gallagher J, Stokes NA, Laufer MR, Hornstein MD, Gordon CM. DiVasta AD, et al. Obstet Gynecol. 2015 Sep;126(3):617-627. doi: 10.1097/AOG.0000000000000964. Obstet Gynecol. 2015. PMID: 26181088 Free PMC article. Clinical Trial.
OBJECTIVE: To assess whether add-back therapy with norethindrone acetate or norethindrone acetate plus conjugated equine estrogens is superior to maintain bone health in adolescents and young women using gonadotropin-releasing hormone …
OBJECTIVE: To assess whether add-back therapy with norethindrone acetate or norethindrone acetate plus conjugated equin …
115 results